Harbourvest Partners LLC Revance Therapeutics, Inc. Transaction History

Harbourvest Partners LLC

  • $188 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020
SELL
$11.66 - $20.15 $307,415 - $531,254
-26,365 Closed
0 $0
Q2 2019

Aug 13, 2019
SELL
$10.67 - $15.49 $2,134 - $3,098
-200 Reduced 0.75%
26,365 $342,000
Q1 2019

May 13, 2019
BUY
$15.4 - $20.39 $409,101 - $541,660
26,565 New
26,565 $419,000

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Harbourvest Partners LLC Portfolio

Follow Harbourvest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbourvest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbourvest Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email